CPT 81253 GJB2 Reimbursement & Policy

CPT code 81253 denotes a targeted laboratory test for detection of known familial mutations in the GJB2 gene (connexin 26). This code captures the technical laboratory component of molecular testing focused on previously identified variants within a patient’s family and is used when a laboratory performs the specific assay to determine presence or absence of those familial mutations. Nationally, this code is relevant for genetic evaluation of hereditary hearing loss and other GJB2-associated conditions where family variant information guides testing.

Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the clinical context for targeted GJB2 testing, the typical laboratory and site-of-service considerations, and what to expect when this code appears on a claim. The publication outlines benchmarks and policy-relevant points such as coverage patterns, billing considerations, and clinical implications of targeted familial variant testing where available. It also highlights areas where input data are not provided and directs readers to seek payer-specific coverage policies and laboratory documentation for claim adjudication.

This summary is intended for a national audience including clinicians, laboratory billing staff, and policy analysts seeking a clear description of CPT code 81253 and its role in targeted genetic testing workflows.

Billing Code Overview

CPT code 81253 describes a targeted molecular diagnostic test performed by a laboratory analyst to detect the presence of known familial mutations in the GJB2 gene (gap junction protein, beta 2; connexin 26). This service focuses on analysis for specific, previously identified pathogenic variants within a patient’s family.

Service type: Targeted genetic testing / molecular diagnostic assay
Typical site of service: Clinical laboratory or molecular diagnostics laboratory (ambulatory or hospital-associated laboratory)

Data not available in the input.

Clinical Context

A patient with a family history of congenital sensorineural hearing loss is referred to a molecular diagnostic laboratory to test for a specific familial mutation in the GJB2 gene (connexin 26). Typical patients include infants or young children with documented hearing loss or adults who are known carriers in the family seeking targeted testing. The clinical workflow begins with a genetics or otolaryngology clinic visit documenting the family mutation and ordering a targeted molecular test using CPT 81253. The laboratory receives the sample (usually blood or buccal swab), verifies the family-specific variant to be tested, performs the targeted assay (e.g., Sanger sequencing or targeted variant analysis), interprets results, and issues a report indicating presence or absence of the familial GJB2 mutation. Reporting includes comparison to the proband/family variant, interpretation of pathogenicity per ACMG guidelines, and recommended follow-up referral to genetics or audiology for positive or inconclusive results. Typical site of service is an outpatient molecular diagnostics laboratory, hospital-based molecular pathology lab, or an ambulatory genetics clinic that collects specimens for send-out testing.

Coding Specifications

Modifier	Description	When to Use
`26`	Professional component	Use when billing only the professional interpretation component and technical component is billed separately.

Taxonomy Code	Specialty	Notes
2080S0010X	Medical Genetics & Genomics	Specialists ordering and interpreting genetic testing.
207H00000X	Otolaryngology	Audiologists/ENTs who refer for GJB2 familial testing for hearing loss.
207K00000X	Pediatrics	Pediatricians managing infants/children with congenital hearing loss.
207L00000X	Pathology	Molecular pathologists performing or overseeing testing in the lab.
208D00000X	Clinical Laboratory	Laboratory directors and clinical laboratory specialists responsible for testing oversight.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`H90.3`	Sensorineural hearing loss, bilateral	Common indication for GJB2 familial testing when congenital or early-onset bilateral sensorineural hearing loss is present.
`H90.5`	Unspecified hearing loss, bilateral	Used when the hearing loss is documented but not yet fully characterized; familial GJB2 testing may be ordered.
`Z15.01`	Genetic susceptibility to deafness	Indicates known family risk; justifies targeted familial mutation testing.
`R42`	Dizziness and giddiness	Less specific but may accompany audiovestibular complaints prompting genetic evaluation in select cases.
`Z13.79`	Encounter for screening for other genetic and chromosomal disorders	Used for asymptomatic family members undergoing targeted familial variant testing.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`81253`	GJB2 (connexin 26) targeted mutation analysis; familial variant(s)	Primary code for targeted testing of a familial GJB2 mutation; used when the lab tests specifically for mutations known in the family.
`81479`	Unlisted molecular pathology procedure	Used when a specific molecular assay performed is not described by an existing CPT code (rare if test methods vary); may be used for nonstandard coverage scenarios.
`81225`	CFTR (cystic fibrosis transmembrane conductance regulator) common variants analysis	Example of another single-gene targeted familial variant test often performed in the same genetic counseling workflow when multiple familial pathogenic variants are assessed.
`81161`	HFE (hemochromatosis) targeted mutation analysis for familial variant(s)	Another example of targeted familial variant testing of a single gene performed in similar laboratory workflows; illustrates parallel billing when multiple familial tests are ordered.
`81445`	Targeted gene sequencing panel, 5-50 genes	Used when broader targeted panel testing is performed instead of single-gene familial testing; may be ordered if familial testing is inconclusive and wider evaluation is needed.

OpenPayer

Summary & Overview

CPT 81253: Targeted Familial Mutation Test for GJB2